Details for 2017783254

Up to date per 21.04.2026

Actions

Title / Product Name

VERFAHREN ZUR BESTIMMUNG UND ERZIELUNG THERAPEUTISCH WIRKSAMER DOSEN VON ANTI-CD47-MITTELN BEI DER BEHANDLUNG VON KREBS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017783254

EP Publication Number

3442578

E-Number

1467108

Language

PCT Number

US17027662

Publication Date

20.02.2019 A

09.02.2022 B1

Registration Date

09.02.2022

AT Publication Date

15.02.2022

Application Date

14.04.2017

Registration Number

Priorities

15.04.2016

201662323330 P

29.11.2016

201662427679 P

IPC

A61K 39/395 20060101AFI20190307BHEP

Maximum Duration of Protection

14.04.2037

Owner

The Board of Trustees of the Leland Stanford Junior UniversityOffice of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386 Stanford, CA 94305-2038US

Representative

Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT

Inventor

WEISSMAN, Irving L.747 Santa Ynez Street Stanford California 94305US

CHAO, Mark P.2001 Showers Drive Mountain View California 94040US

MAJETI, Ravindra861 Newell Place Palo Alto California 94303US

LIU, Jie3119 Stockton Place Palo Alto California 94303US

VOLKMER, Jens-Peter752 Live Oak Ave. Apt. 4 Menlo Park California 94025US

Information about Fees